REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Cutia Therapeutics (科笛集团) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Cutia Therapeutics Profile Updated: April 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Cutia Therapeutics (科笛集团) is an enterprise in China, with the main office in Shanghai. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on May 15, 2019. It currently has a total number of 304 (2025) employees. There was a net sales revenue increase of 20.22% reported in Cutia Therapeutics (科笛集团)’s latest financial highlights for 2025. Over the same period, its total assets decreased by 6.24%. The net profit margin of Cutia Therapeutics (科笛集团) increased by 53.95% in 2025.

Headquarters
20/F, Huanzhi Building, 436 Heng Feng Road, Jingan District
Shanghai; Shanghai;

Contact Details: Purchase the Cutia Therapeutics (科笛集团) report to view the information.

Website: http://www.cutiatx.com

Basic Information
Total Employees:
Purchase the Cutia Therapeutics (科笛集团) report to view the information.
Outstanding Shares:
Purchase the Cutia Therapeutics (科笛集团) report to view the information.
Registered Capital:
Purchase the Cutia Therapeutics (科笛集团) report to view the information.
Financial Auditors:
Purchase the Cutia Therapeutics (科笛集团) report to view the information.
Incorporation Date:
May 15, 2019
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
19.31%
Purchase this report to view the information.
18.91%
Purchase this report to view the information.
16.88%
Purchase this report to view the information.
12.38%
Purchase this report to view the information.
8.11%
Subsidiaries
Cutia Therapeutics (Hk) Limited (Hong Kong SAR, China)
100%
Company Performance
Financial values in the chart are available after Cutia Therapeutics (科笛集团) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
20.22%▲
Total Operating Revenue
20.77%▲
Operating Profit
28.48%▲
EBITDA
20.71%▲
Net Profit/Loss for the Period
21.58%▲
Total Assets
-6.24%▼
Total Equity
-9.18%▼
Operating Profit Margin
66.44%▲
Net Profit Margin
53.95%▲
Return on Equity (ROE)
6.08%▲
Debt / Equity
2.92%▲
Quick Ratio
0.6%▲
Cash Ratio
-0.21%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
JD Health International Inc.
Wuxi Apptec Co.,Ltd.
 
Nanjing Pharmaceutical Group Company Limited
Ab B Bio-Tech Co., Ltd. Js (Taizhou) (江苏中慧元通生物科技股份有限公司 (台州))
 
HBM Holdings Limited
Guangdong Winsun Bio-Pharmaceutical Co., Ltd. (Guangzhou) (广东永顺生物制药股份有限公司 (广州))
 
Zhejiang Xinguang Pharmaceutical Co., Ltd.
Sailong Pharmaceutical Group Co.,Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo